Because of the high association of the risk of cardiovascular events with age-related macular degeneration, diabetes, and retinal vein occlusion [35]–[37], the results of a previous meta-analysis [13], which revealed intravitreal anti-VEGF was also associated with an increased risk of cerebrovascular accidents, was worrisome. This evidence concerns the gene VEGFA and age-related macular degeneration.